Katy Jeannot Professeur Universitaire- Praticien Hospitalier Bactériologie

Identifiants chercheurs

IdHAL :

katy-jeannot

ORCID :

0000-0002-4634-8550

IdRef :

124332579

Présentation

Mes travaux de recherche s’articulent autour de plusieurs axes :

Mécanismes d’adaptation de

P. aeruginosa

et

A. baumannii

aux peptides antimicrobiens- Mécanismes de résistance aux antibiotiques des souches cliniques de

Pseudomonas

spp. et

Acinetobacter

spp. (épidémiologie, supports génétiques, transferts, caractéristiques phénotypiques)

Substrats et régulation des systèmes d’efflux actif de

P. aeruginosa

(voies de régulation/signalisation, réponse aux stress)

Evolution phénotypique et génotypique des souches de P. aeruginosa colonisant l’arbre bronchique des patients atteints de mucoviscidose

Mécanismes d’adaptation de

P. aeruginosa

et

A. baumannii

aux peptides antimicrobiens

Publications

Article dans une revue (82)

Role of Cefiderocol in the Treatment of Carbapenem-Resistant Nonfermenting Gram-Negative Bacilli (Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia) Infections: An Expert Statement Alexandre Bleibtreu,Youssef Bennis,Aurélien Dinh,Hervé Dupont,Arnaud Friggeriet al. Infectious Diseases and Therapy, 2026, ⟨10.1007/s40121-026-01301-y⟩ Article dans une revue hal-05495603v1
Cefiderocol susceptibility testing: the challenge of disc diffusion Katy Jeannot,Laurent Dortet,Marlène Amara,Olivier Barraud,Julien Cadenetet al. Clinical Microbiology and Infection, 2025, ⟨10.1016/j.cmi.2024.12.037⟩ Article dans une revue hal-04935151v1
Uncovering a new family of conserved virulence factors that promote the production of host‐damaging outer membrane vesicles in gram‐negative bacteria Audrey Goman,Bérengère Ize,Katy Jeannot,Camille Pin,Delphine Payroset al. Journal of Extracellular Vesicles, 2025, 14 (1), pp.e270032. ⟨10.1002/jev2.70032⟩ Article dans une revue hal-04907628v1
Mycoplasma pneumoniae infection in adult inpatients during the 2023–24 outbreak in France (MYCADO): a national, retrospective, observational study Ariane Gavaud,Matthieu Holub,Antoine Asquier-Khati,Karine Faure,Sophie Leautez-Nainvilleet al. The Lancet Infectious Diseases, 2025, ⟨10.1016/S1473-3099(24)00805-3⟩ Article dans une revue hal-04966717v1
In vitro activity of cefepime-enmetazobactam on carbapenem-resistant Gram negatives Rémy A Bonnin,Katy Jeannot,Anne Santerre Henriksen,Juan Quevedo,Laurent Dortet Clinical Microbiology and Infection, 2025, 31 (2), pp.240-249. ⟨10.1016/j.cmi.2024.09.031⟩ Article dans une revue hal-04935159v1
$Pseudomonas\ aeruginosa$ antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group Antonio Oliver,Estrella Rojo-Molinero,Jorge Arca-Suarez,Yeşim Beşli,Pierre Bogaertset al. Clinical Microbiology and Infection, In press, 30 (4), pp.469-480. ⟨10.1016/j.cmi.2023.12.026⟩ Article dans une revue hal-04384072v1
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations Anne Santerre Henriksen,Fabio Arena,Marie Attwood,Rafael Canton,Sören Gatermannet al. Microbiology Spectrum, 2024, 12 (8), pp.e0418123. ⟨10.1128/spectrum.04181-23⟩ Article dans une revue hal-05469928v1
&lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; MipA-MipB envelope proteins act as new sensors of polymyxins Manon Janet-Maitre,Viviana Job,Maxime Bour,Mylène Robert-Genthon,Sabine Brugièreet al. mBio, 2024, 15 (3), pp.e0221123. ⟨10.1128/mbio.02211-23⟩ Article dans une revue hal-04732591v1
National Cohort of Compassionate Use of Meropenem–Vaborbactam: No Benefit over Meropenem for Pseudomonas aeruginosa Aurélien Dinh,Alexandre Bleibtreu,Clara Duran,Frédérique Bouchand,Alexie Boschet al. Antibiotics, 2024, 13 (12), pp.1152. ⟨10.3390/antibiotics13121152⟩ Article dans une revue inserm-04874028v1
Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus Vincent Jean-Pierre,Pauline Sorlin,Katy Jeannot,Raphaël Chiron,Jean-Philippe Lavigneet al. Annals of Clinical Microbiology and Antimicrobials, 2024, 23 (1), pp.78. ⟨10.1186/s12941-024-00731-1⟩ Article dans une revue hal-04873210v1
Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains Vincent Jean-Pierre,Pauline Sorlin,Alix Pantel,Raphaël Chiron,Jean-Philippe Lavigneet al. Annals of Clinical Microbiology and Antimicrobials, 2024, 23 (1), pp.54. ⟨10.1186/s12941-024-00709-z⟩ Article dans une revue hal-04874108v1
Mutations in genes lpxL1 , bamA , and pmrB impair the susceptibility of cystic fibrosis strains of Pseudomonas aeruginosa to murepavadin Aya Ghassani,Pauline Triponney,Maxime Bour,Patrick Plésiat,Katy Jeannot Antimicrobial Agents and Chemotherapy, 2024, 68 (1), pp.e0129823. ⟨10.1128/aac.01298-23⟩ Article dans une revue hal-04668725v1
Comment on “Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020–2021” H. Marchandin,L. Dubreuil,Marlène Amara,Guillaume Aubin,François Caronet al. Anaerobe, 2024, 90, pp.102910. ⟨10.1016/j.anaerobe.2024.102910⟩ Article dans une revue (article de synthèse) hal-04873136v1
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations Anne Santerre Henriksen,Katy Jeannot,Antonio Oliver,John D Perry,Mathias W Pletzet al. Microbiology Spectrum, 2024, 12 (4), pp.e0383623. ⟨10.1128/spectrum.03836-23⟩ Article dans une revue hal-05469900v1
Evaluation of the Efficiency of Random and Diblock Methacrylate-Based Amphiphilic Cationic Polymers against Major Bacterial Pathogens Associated with Cystic Fibrosis Magali Casanova,Hamza Olleik,Slim Hdiouech,Clarisse Roblin,Jean-François Cavalieret al. Antibiotics, 2023, 12 (1), pp.120. ⟨10.3390/antibiotics12010120⟩ Article dans une revue (article de synthèse) hal-03998029v1
Evaluation of 5 rapid colorimetric and immunochromatographic tests for the detection of carbapenemases in Pseudomonas aeruginosa and Acinetobacter spp. isolates Damien Fournier,Pauline Triponney,Loreen Gabriel,Patrick Plésiat,Katy Jeannotet al. European Journal of Clinical Microbiology and Infectious Diseases, 2023, 42 (8), pp.1043-1045. ⟨10.1007/s10096-023-04631-8⟩ Article dans une revue hal-04225777v1
Whole-Genome Sequencing of 11 High-Risk Clone ST111 Pseudomonas aeruginosa Isolates from French Hospitals Mikkel Anbo,Mariana Antonova Tavares Chichkova,Yilmaz Emre Gençay,Alex Salazar,Katy Jeannotet al. Microbiology Resource Announcements, 2023, 12 (7), pp.e0009123. ⟨10.1128/mra.00091-23⟩ Article dans une revue hal-04318326v1
Genomic characterization of an NDM-9-producing $Acinetobacter\ baumannii$ clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9 Susie Gaillot,Saoussen Oueslati,Jean-Baptiste Vuillemenot,Maxime Bour,Bogdan Iorgaet al. Frontiers in Microbiology, 2023, 14, pp.1253160. ⟨10.3389/fmicb.2023.1253160⟩ Article dans une revue hal-04204833v1
Cefiderocol activity is compromised by acquired extended-spectrum oxacillinases in Pseudomonas aeruginosa Xavier Vuillemin,Maëlle da Silva,Maxime Bour,Céline Landon,Patrick Plésiatet al. International Journal of Antimicrobial Agents, 2023, 62 (3), pp.106917. ⟨10.1016/j.ijantimicag.2023.106917⟩ Article dans une revue hal-04225762v1
6-Polyaminosteroid Squalamine Analogues Display Antibacterial Activity against Resistant Pathogens Delphine Vergoz,Flore Nilly,Florie Desriac,Magalie Barreau,Antoine Géryet al. International Journal of Molecular Sciences, 2023, 24 (10), pp.8568. ⟨10.3390/ijms24108568⟩ Article dans une revue hal-04161494v1
French national epidemiology of bacterial superinfections in ventilator-associated pneumonia in patients infected with COVID-19: the COVAP study Maxime Pichon,Julie Cremniter,Christophe Burucoa,Sahar Abdallah,Corentine Alauzetet al. Annals of Clinical Microbiology and Antimicrobials, 2023, 22 (1), pp.50. ⟨10.1186/s12941-023-00603-0⟩ Article dans une revue hal-04636712v1
Performance of the Disc Diffusion Method, MTS Gradient Tests and Two Commercially Available Microdilution Tests for the Determination of Cefiderocol Susceptibility in Acinetobacter spp. Katy Jeannot,Susie Gaillot,Pauline Triponney,Sylvain Portets,Valentin Pourchetet al. Microorganisms, 2023, 11 (8), pp.1971. ⟨10.3390/microorganisms11081971⟩ Article dans une revue hal-04225792v1
Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant Pseudomonas aeruginosa to cefiderocol Léa Devoos,Adrien Biguenet,Julie Rousselot,Maxime Bour,Patrick Plésiatet al. Clinical Microbiology and Infection, 2023, 29 (5), pp.652.e1-652.e8. ⟨10.1016/j.cmi.2022.12.021⟩ Article dans une revue hal-04225818v1
Genomic erosion and horizontal gene transfer shape functional differences of the ExlA toxin in Pseudomonas spp. Viviana Job,Laura Gomez-Valero,Adèle Renier,Christophe Rusniok,Stephanie Bouillotet al. iScience, 2022, 25 (7), pp.104596. ⟨10.1016/j.isci.2022.104596⟩ Article dans une revue hal-03725826v1
Role of megaplasmids and chromosomal integration in acquisition of CTX-M-encoding genes by Pseudomonas aeruginosa Pauline Triponney,Maxime Bour,Racha Beyrouthy,Richard Bonnet,Patrick Plésiatet al. Journal of Antimicrobial Chemotherapy, 2022, 77 (11), pp.3194-3198. ⟨10.1093/jac/dkac302⟩ Article dans une revue hal-03880013v1
Reassessment of the cooperativity between efflux system MexAB-OprM and cephalosporinase AmpC in the resistance of Pseudomonas aeruginosa to β-lactams Patrick Plésiat,Katy Jeannot,Mélanie Grosjean,Sara Tazrout,Maxime Bouret al. Journal of Antimicrobial Chemotherapy, 2021, 76 (2), pp.536-539. ⟨10.1093/jac/dkaa462⟩ Article dans une revue hal-03504036v1
Detection of Colistin Resistance in Pseudomonas aeruginosa Using the MALDIxin Test on the Routine MALDI Biotyper Sirius Mass Spectrometer Katy Jeannot,Katheryn Hagart,Laurent Dortet,Markus Kostrzewa,Alain Fillouxet al. Frontiers in Microbiology, 2021, 12, ⟨10.3389/fmicb.2021.725383⟩ Article dans une revue hal-03503853v1
An unusual digestive infection due to Francisella tularensis: A case report A. Zeggay,R. Anxionnat,C. Chirouze,P. Plésiat,K. Jeannotet al. Infectious Diseases Now, 2021, ⟨10.1016/j.idnow.2021.02.001⟩ Article dans une revue hal-03369690v1
Performance of disc diffusion, MIC gradient tests and Vitek 2 for ceftolozane/tazobactam and ceftazidime/avibactam susceptibility testing of Pseudomonas aeruginosa Brice Daragon,Damien Fournier,Patrick Plésiat,Katy Jeannot Journal of Antimicrobial Chemotherapy, 2021, 76 (10), pp.2586-2592. ⟨10.1093/jac/dkab236⟩ Article dans une revue hal-04225887v1
Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study Damien Fournier,Romain Carrière,Maxime Bour,Emilie Grisot,Pauline Triponneyet al. Antimicrobial Agents and Chemotherapy, 2021, 65 (2), ⟨10.1128/AAC.01117-20⟩ Article dans une revue hal-04225901v1
Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study Damien Fournier,Romain Carrière,Maxime Bour,Emilie Grisot,Pauline Triponneyet al. Antimicrobial Agents and Chemotherapy, 2021, 65 (2), ⟨10.1128/AAC.01117-20⟩ Article dans une revue hal-04001419v1
Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa : Results of the GERPA Multicenter Study Damien Fournier,Romain Carrière,Maxime Bour,Emilie Grisot,Pauline Triponneyet al. Antimicrobial Agents and Chemotherapy, 2020, ⟨10.1128/AAC.01117-20⟩ Article dans une revue hal-03028399v1
Number, type and cost of microbiological tests during HIV Pre-Exposure Prophylaxis: The experience of a French hospital M. Morgat,K. Bouiller,J.B. Vuillemenot,L. Puget,S. Marty-Quinternetet al. Médecine et Maladies Infectieuses (1971-2020), 2020, ⟨10.1016/j.medmal.2020.10.017⟩ Article dans une revue hal-03064676v1
The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin Hélène Puja,Arnaud Bolard,Aurélie Noguès,Patrick Plésiat,Katy Jeannot Antimicrobial Agents and Chemotherapy, 2020, 64 (4), ⟨10.1128/AAC.02033-19⟩ Article dans une revue hal-02533667v1
Coordinate overexpression of two RND efflux systems, ParXY and TtgABC , is responsible for multidrug resistance in Pseudomonas putida Hélène Puja,Gwendoline Comment,Sophie Chassagne,Patrick Plésiat,Katy Jeannot Environmental Microbiology, 2020, 22 (12), pp.5222-5231. ⟨10.1111/1462-2920.15200⟩ Article dans une revue hal-03482928v1
The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties Clarisse Roblin,Steve Chiumento,Olivier Bornet,Matthieu Nouailler,Christina S. Mülleret al. Proceedings of the National Academy of Sciences of the United States of America, 2020, 117 (32), pp.19168-19177. ⟨10.1073/pnas.2302405120⟩ Article dans une revue hal-02920462v1
Novel Synthesis and Characterization of Doxycycline-Loaded Gold Nanoparticles: The Golden Doxycycline for Antibacterial Applications Maroua Ben Haddada,Katy Jeannot,Jolanda Spadavecchia Particle & Particle Systems Characterization, 2019, 36 (2), pp.1800395. ⟨10.1002/ppsc.201800395⟩ Article dans une revue hal-03483137v1
A novel IncQ plasmid carrying gene bla CTX-M-3 in Pseudomonas aeruginosa Katy Jeannot,Marion Danassie,Pauline Triponney,Maxime Bour,Thomas Gueudetet al. Journal of Antimicrobial Chemotherapy, 2019, 74 (3), pp.823-825. ⟨10.1093/jac/dky454⟩ Article dans une revue hal-02064640v1
Production of Norspermidine Contributes to Aminoglycoside Resistance in pmrAB Mutants of Pseudomonas aeruginosa Arnaud Bolard,Monika Schniederjans,Susanne Haüssler,Pauline Triponney,Benoit Valotet al. Antimicrobial Agents and Chemotherapy, 2019, 63 (10), pp.e01044-19. ⟨10.1128/AAC.01044-19⟩ Article dans une revue hal-02438158v1
Azetidine-Containing Alkaloids Produced by a Quorum-Sensing Regulated Nonribosomal Peptide Synthetase Pathway in Pseudomonas aeruginosa Zhilai Hong,Arnaud Bolard,Caroline Giraud,Sébastien Prevost,Grégory Genta-Jouveet al. Angewandte Chemie International Edition, 2019, 58 (10), pp.3178-3182. ⟨10.1002/anie.201809981⟩ Article dans une revue hal-02096769v1
Editorial: Horizontal Gene Transfer Mediated Bacterial Antibiotic Resistance Katy Jeannot,Dongchang Sun,Yonghong Xiao,Charles Knapp Frontiers in Microbiology, 2019, 10 (12), pp.19168-19177. ⟨10.3389/fmicb.2019.01933⟩ Article dans une revue hal-03505272v1
Identification of Diverse Integron and Plasmid Structures Carrying a Novel Carbapenemase Among Pseudomonas Species Eleni Liapis,Maxime Bour,Pauline Triponney,Thomas Jové,Jean-Ralph Zaharet al. Frontiers in Microbiology, 2019, 10, pp.404. ⟨10.3389/fmicb.2019.00404⟩ Article dans une revue hal-02438246v1
Acquisition of Class C β-Lactamase PAC-1 by Sequence Type 644 Strains of Pseudomonas aeruginosa Maxime Bour,Damien Fournier,Thomas Jové,Armelle Pouzol,Guillaume Miltgenet al. Antimicrobial Agents and Chemotherapy, 2019, 63 (12), pp.1469-1472. ⟨10.1128/AAC.01375-19⟩ Article dans une revue hal-04225913v1
A novel IncQ plasmid carrying gene bla CTX-M-3 in Pseudomonas aeruginosa Katy Jeannot,Marion Danassie,Pauline Triponney,Maxime Bour,Thomas Gueudetet al. Journal of Antimicrobial Chemotherapy, 2019, 74 (3), pp.823-825. ⟨10.1093/jac/dky454⟩ Article dans une revue hal-03483121v1
Drug susceptibility testing by dilution methods. Katy Jeannot,Patrick Plesiat Methods in Molecular Biology, 2018, pp.49-58. ⟨10.1007/978-1-4939-0473-0_6⟩ Article dans une revue hal-01688749v1
Novel Synthesis and Characterization of Doxycycline-Loaded Gold Nanoparticles: The Golden Doxycycline for Antibacterial Applications Maroua Ben Haddada,Katy Jeannot,Jolanda Spadavecchia Particle & Particle Systems Characterization, In press, 36 (2), pp.1800395. ⟨10.1002/ppsc.201800395⟩ Article dans une revue hal-02353307v1
Toxic Electrophiles Induce Expression of the Multidrug Efflux Pump MexEF-OprN in Pseudomonas aeruginosa through a Novel Transcriptional Regulator, CmrA Paulo Juarez,Katy Jeannot,Patrick Plesiat,Catherine Llanes Antimicrobial Agents and Chemotherapy, 2017, 61 (8), ⟨10.1128/AAC.00585-17⟩ Article dans une revue hal-01685302v1
Resistance of Animal Strains of Pseudomonas aeruginosa to Carbapenems Marisa Haenni,Maxime Bour,Pierre Châtre,Jean-Yves Madec,Patrick Plesiatet al. Frontiers in Microbiology, 2017, 8, pp.1847. ⟨10.3389/fmicb.2017.01847⟩ Article dans une revue hal-01685271v1
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate Mohamed Al-Agamy,Katy Jeannot,Taghrid El-Mahdy,Atef Shibl,Wael Kattanet al. Microbial Drug Resistance, 2017, 23 (5), pp.556 - 562. ⟨10.1089/mdr.2016.0152⟩ Article dans une revue hal-01689432v1
Mutations in gene fusA1 as a novel mechanism of aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa Arnaud Bolard,Patrick Plesiat,Katy Jeannot Antimicrobial Agents and Chemotherapy, 2017, 145, pp.66 - 68. ⟨10.1128/AAC.01835-17⟩ Article dans une revue hal-01685252v1
A case of multiple contamination with methylase ArmA-producing pathogens A Janvier,P. Otto,Thomas Jové,C. Mille,C. Contargyriset al. Journal of Antimicrobial Chemotherapy, 2017, 72 (2), pp.618 - 620. ⟨10.1093/jac/dkw418⟩ Article dans une revue hal-01690698v1
Resistance to polymyxins in Gram-negative organisms Katy Jeannot,Arnaud Bolard,Patrick Plesiat International Journal of Antimicrobial Agents, 2017, 49 (5), pp.526 - 535. ⟨10.1016/j.ijantimicag.2016.11.029⟩ Article dans une revue hal-01687685v1
Amino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosa Charlotte Richardot,Paulo Juarez,Katy Jeannot,Isabelle Patry,Patrick Plesiatet al. Antimicrobial Agents and Chemotherapy, 2016, 60 (4), pp.2302 - 2310. ⟨10.1128/AAC.02622-15⟩ Article dans une revue hal-01687774v1
Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia Mohamed Al-Agamy,Katy Jeannot,Taghrid S El-Mahdy,Hassan A Samaha,Atef Shiblet al. Canadian Journal of Infectious Diseases and Medical Microbiology, 2016, 2016, pp.4379686. ⟨10.1155/2016/4379686⟩ Article dans une revue hal-01687716v1
Phenotype and toxicity of the recently discovered exlA -positive Pseudomonas aeruginosa strains collected worldwide Emeline Reboud,Sylvie Elsen,Stéphanie Bouillot,Guillaume Golovkine,Katy Jeannotet al. Environmental Microbiology, 2016, 18 (10), pp.3425 - 3439. ⟨10.1111/1462-2920.13262⟩ Article dans une revue istex hal-01687748v1
Type III Secretion System and Virulence Markers Highlight Similarities and Differences between Human- and Plant-Associated Pseudomonads Related to Pseudomonas fluorescens and P. putida Sylvie Mazurier,Annabelle Mérieau,Dorian Bergeau,Victorien Decoin,Daniel Sperandioet al. Applied and Environmental Microbiology, 2015, 81 (7), pp.2579 - 2590. ⟨10.1128/AEM.04160-14⟩ Article dans une revue hal-01689621v1
Genetic and Biochemical Characterization of OXA-405, an OXA-48-Type Extended-Spectrum β-Lactamase without Significant Carbapenemase Activity Saoussen Oueslati,Katy Jeannot,Didier Tandé,Thierry Naas,Patrice Nordmannet al. Antimicrobial Agents and Chemotherapy, 2015, 59 (7), pp.3823 - 3828. ⟨10.1128/AAC.05058-14⟩ Article dans une revue hal-01689515v1
Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins M. Berrazeg,K. Jeannot,V.Y. Ntsogo Enguéné,I. Broutin,S. Loeffertet al. Antimicrobial Agents and Chemotherapy, 2015, 59 (10), pp.6248 - 6255. ⟨10.1128/AAC.00825-15⟩ Article dans une revue hal-01693067v1
Antibiotic Resistance Determinants in a Pseudomonas putida Strain Isolated from a Hospital Lázaro Molina,Zulema Udaondo,Estrella Duque,Matilde Fernández,Carlos Molina-Santiagoet al. PLoS ONE, 2014, 9 (1), pp.e81604. ⟨10.1371/journal.pone.0081604⟩ Article dans une revue hal-01688754v1
New Amphiphilic Neamine Derivatives Active against Resistant Pseudomonas aeruginosa and Their Interactions with Lipopolysaccharides Guillaume Sautrey,Louis Zimmermann,Magali Deleu,Alicia Delbar,Luiza Souza Machadoet al. Antimicrobial Agents and Chemotherapy, 2014, 58 (8), pp.4420 - 4430. ⟨10.1128/AAC.02536-13⟩ Article dans une revue hal-01696330v1
Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment. Céline Lucchetti-Miganeh,David Redelberger,Gaël Chambonnier,François Rechenmann,Sylvie Elsenet al. Pathogens, 2014, 3 (2), pp.309--40. ⟨10.3390/pathogens3020309⟩ Article dans une revue hal-01458212v1
Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France. Katy Jeannot,Laure Diancourt,Sophie Vaux,Michelle Thouverez,Amandina Ribeiroet al. PLoS ONE, 2013, 9 (12), pp.e115452. ⟨10.1371/journal.pone.0115452⟩ Article dans une revue hal-01114942v1
Clonal dissemination of Pseudomonas aeruginosa isolates producing extended-spectrum β-lactamase SHV-2a. Katy Jeannot,Damien Fournier,Emeline Müller,Pascal Cholley,Patrick Plésiat Journal of Clinical Microbiology, 2013, 51 (2), pp.673-5. ⟨10.1128/JCM.02313-12⟩ Article dans une revue hal-00802872v1
Molecular Characterization of bla NDM-1 in a Sequence Type 235 Pseudomonas aeruginosa Isolate from France Frederic Janvier,Katy Jeannot,Sophie Tesse,Marjorie Robert-Nicoud,Hervé Delacouret al. Antimicrobial Agents and Chemotherapy, 2013, 57 (7), pp.3408 - 3411. ⟨10.1128/AAC.02334-12⟩ Article dans une revue hal-01688793v1
Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa Damien Fournier,Charlotte Richardot,Emeline Muller,Marjorie Robert-Nicoud,Catherine Llaneset al. Journal of Antimicrobial Chemotherapy, 2013, 68 (8), pp.1772 - 1780. ⟨10.1093/jac/dkt098⟩ Article dans une revue hal-01688805v1
Outbreak of metallo- -lactamase VIM-2-positive strains of Pseudomonas aeruginosa in the Ivory Coast Katy Jeannot,Nathalie Guessennd,Damien Fournier,Emeline Muller,Valérie Gbononet al. Journal of Antimicrobial Chemotherapy, 2013, 68 (12), pp.2952 - 2954. ⟨10.1093/jac/dkt296⟩ Article dans une revue hal-01688778v1
Multiple Mutations Lead to MexXY-OprM-Dependent Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa Sophie Guénard,Cédric Muller,Laura Monlezun,Philippe Bénas,Isabelle Broutinet al. Antimicrobial Agents and Chemotherapy, 2013, 58 (1), pp.221 - 228. ⟨10.1128/AAC.01252-13⟩ Article dans une revue hal-01688763v1
A Convenient Method To Screen for Carbapenemase-Producing Pseudomonas aeruginosa Damien Fournier,Pauline Garnier,Katy Jeannot,Amélie Mille,Anne-Sophie Gomezet al. Journal of Clinical Microbiology, 2013, 51 (11), pp.3846 - 3848. ⟨10.1128/JCM.01299-13⟩ Article dans une revue hal-01688773v1
IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa. Katy Jeannot,Laurent Poirel,Marjorie Robert-Nicoud,Pascal Cholley,Patrice Nordmannet al. Antimicrobial Agents and Chemotherapy, 2012, 56 (4), pp.2187-90. ⟨10.1128/AAC.05838-11⟩ Article dans une revue hal-00668254v1
Unique biofilm signature, drug susceptibility and decreased virulence in Drosophila through the Pseudomonas aeruginosa two-component system PprAB. Sophie de Bentzmann,Caroline Giraud,Christophe S. Bernard,Virginie Calderon,Friederike Ewaldet al. PLoS Pathogens, 2012, 8 (11), pp.e1003052. ⟨10.1371/journal.ppat.1003052⟩ Article dans une revue inserm-00905018v1
Spread of the bla(IMP-13) gene in French Pseudomonas aeruginosa through sequence types ST621, ST308 and ST111. Damien Fournier,Katy Jeannot,Marjorie Robert-Nicoud,Emeline Muller,Pascal Cholleyet al. International Journal of Antimicrobial Agents, 2012, 40 (6), pp.571-3. ⟨10.1016/j.ijantimicag.2012.08.006⟩ Article dans une revue istex hal-00802874v1
Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012. C Flateau,F Janvier,D. Delacour,S Males,C Fickoet al. Eurosurveillance, 2012 Article dans une revue hal-01696341v1
A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and β-Lactams in Pseudomonas aeruginosa Cédric Muller,Patrick Plesiat,Katy Jeannot Antimicrobial Agents and Chemotherapy, 2011, 55 (3), pp.1211 - 1221. ⟨10.1128/AAC.01252-10⟩ Article dans une revue hal-01695642v1
Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. Cathy A Petti,Keith E Simmon,Jose M Miro,Bruno Hoen,Francesc Marcoet al. Journal of Clinical Microbiology, 2008, 46 (5), pp.1780-4. ⟨10.1128/JCM.02405-07⟩ Article dans une revue hal-00464779v1
Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. Cathy A Petti,Keith E Simmon,Jose M Miro,Bruno Hoen,Francesc Marcoet al. Journal of Clinical Microbiology, 2008, 46 (5), pp.1780-4. ⟨10.1128/JCM.02405-07⟩ Article dans une revue hal-00465371v1
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. K. Jeannot,S. Elsen,T. Köhler,I. Attree,C. van Deldenet al. Antimicrob Agents Chemother, 2008, pp.52(7):2455-62 Article dans une revue hal-00496242v1
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. Katy Jeannot,Sylvie Elsen,Thilo Köhler,Ina Attree,Christian van Deldenet al. Antimicrobial Agents and Chemotherapy, 2008, 52 (7), pp.2455-62. ⟨10.1128/AAC.01107-07⟩ Article dans une revue hal-00338491v1
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Didier Hocquet,Philippe Berthelot,Micheline Roussel-Delvallez,Roger Favre,Katy Jeannotet al. Antimicrobial Agents and Chemotherapy, 2007, 51 (10), pp.3531-6. ⟨10.1128/AAC.00503-07⟩ Article dans une revue hal-00464781v1
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Farid El'Garch,Katy Jeannot,Didier Hocquet,Catherine Llanes-Barakat,Patrick Plésiat Antimicrobial Agents and Chemotherapy, 2007, 51 (3), pp.1016-21. ⟨10.1128/AAC.00704-06⟩ Article dans une revue hal-00464783v1
Induction of the MexXY Efflux Pump in Pseudomonas aeruginosa Is Dependent on Drug-Ribosome Interaction Katy Jeannot,Mara Sobel,Farid El Garch,Keith Poole,Patrick Plesiat Journal of Bacteriology, 2005, 187 (15), pp.5341 - 5346. ⟨10.1128/JB.187.15.5341-5346.2005⟩ Article dans une revue hal-01696215v1
Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa Philippe Dupont,Didier Hocquet,Katy Jeannot,Pascal Chavanet,Patrick Plesiat Journal of Antimicrobial Chemotherapy, 2005, 55 (4), pp.518 - 522. ⟨10.1093/jac/dki030⟩ Article dans une revue hal-01696246v1
[Low-level resistance to fluoroquinolones conferred by efflux overproduction in Pseudomonas aeruginosa: clinical significance and routine detection]. Pierre Dupont,M. Bize,K. Jeannot,Pascal Chavanet,P. Plésiatet al. Pathologie Biologie, 2005, 53 (8-9), pp.495 - 499. ⟨10.1016/j.patbio.2005.08.005⟩ Article dans une revue istex hal-01696209v1

Communication dans un congrès (3)

Multirésistance de Pseudomonas aeruginosa : une nouvelle voie d’induction CmrA-dépendante du système d’efflux MexEF-OprN Paulo Juarez,Katy Jeannot,Patrick Plésiat,Catherine Llanes 18ème colloque français des Jeunes Chercheurs travaillant sur la Mucoviscidose, Feb 2017, Paris, France Communication dans un congrès hal-03527383v1
Carbonyl stress induces the efflux system MexEF-OprN in Pseudomonas aeruginosa via a novel transcriptional regulator, CmrA Paulo Juarez,Patrick Plésiat,Katy Jeannot,Catherine Llanes GORDON Research Conferences, Mar 2017, Galveston, United States Communication dans un congrès hal-03526690v1
Effet du nouvel activateur transcriptionnel CmrA sur la résistance et la virulence des souches de Pseudomonas aeruginosa Paulo Juarez,Katy Jeannot,Patrick Plésiat,Catherine Llanes 17ème colloque français des Jeunes Chercheurs travaillant sur la Mucoviscidose, Feb 2016, Paris, France Communication dans un congrès hal-03527371v1

Poster de conférence (2)

Les poupées russes de l’antibiorésistance - cartographie hiérarchique des gènes et des vecteurs de résistance transférable Adrian Zurmely,Natacha Lenuzza,Bénédicte Lafay,Aurélie Fischer,Laetitia Hénaffet al. 45e Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse (RICAI), Dec 2025, Paris, France. 2021 Poster de conférence hal-05454840v1
P229 Do CFTR modulators interfere with microbiological diagnosis? G. Héry-Arnaud,S. Vallet,M.-E. Bougnoux,E. Cardot-Martin,S. Cassainget al. ECFC (European Cystic Fibrosis Conference), Jun 2024, Glasgow, United Kingdom. 23, pp.S139, 2024, ⟨10.1016/S1569-1993(24)00533-2⟩ Poster de conférence hal-04609383v1